机构:[1]Department of Oncology, Peking University Shenzhen Hospital, Shenzhen, China北京大学深圳医院深圳市康宁医院深圳医学信息中心[2]Huizhou Municipal Center Hospital, Huizhou, China[3]Dongguan People's Hospital, Dongguan, China[4]Huizhou First People's Hospital, Huizhou, China[5]Shenzhen Second People's Hospital, Shenzhen, China深圳市第二人民医院深圳医学信息中心[6]Shenzhen Nanshan Hospital, Shenzhen, China[7]Department of Oncology, Baoan District Traditional Chinese Medicine Hospital of Shenzhen, Shenzhen, China深圳市康宁医院深圳医学信息中心[8]Huizhou Sixth People's Hospital, Huizhou, China[9]Huizhou Traditional Chinese Medicine Hospital, Huizhou, China[10]Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, China广东省中医院[11]Department of Oncology, Longgang District Central Hospital of Shenzhen, Shenzhen, China深圳市康宁医院深圳市龙岗区中心医院深圳医学信息中心[12]Department of Oncology, People's Hospital of Shanwei, Shanwei, China[13]Department of Oncology, Second People's Hospital of Shanwei, Shanwei, China[14]Department of Oncology, Pengpai Memorial Hospital of Haifeng, Haifeng, China[15]Peking University-Hong Kong University of Science and Technology Medical Center, Shenzhen, China
第一作者机构:[1]Department of Oncology, Peking University Shenzhen Hospital, Shenzhen, China[2]Huizhou Municipal Center Hospital, Huizhou, China[3]Dongguan People's Hospital, Dongguan, China[4]Huizhou First People's Hospital, Huizhou, China[5]Shenzhen Second People's Hospital, Shenzhen, China[6]Shenzhen Nanshan Hospital, Shenzhen, China[7]Department of Oncology, Baoan District Traditional Chinese Medicine Hospital of Shenzhen, Shenzhen, China[8]Huizhou Sixth People's Hospital, Huizhou, China[9]Huizhou Traditional Chinese Medicine Hospital, Huizhou, China[10]Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, China[11]Department of Oncology, Longgang District Central Hospital of Shenzhen, Shenzhen, China[12]Department of Oncology, People's Hospital of Shanwei, Shanwei, China[13]Department of Oncology, Second People's Hospital of Shanwei, Shanwei, China[14]Department of Oncology, Pengpai Memorial Hospital of Haifeng, Haifeng, China[15]Peking University-Hong Kong University of Science and Technology Medical Center, Shenzhen, China
推荐引用方式(GB/T 7714):
Wang Fen,Wang Shubin,Yuan Xia,et al.Apatinib monotherapy for chemotherapy-refractory metastatic colorectal cancer: A multicenter, single arm, prospective study.[J].JOURNAL OF CLINICAL ONCOLOGY.2019,37(15):doi:10.1200/JCO.2019.37.15_suppl.3527.
APA:
Wang, Fen,Wang, Shubin,Yuan, Xia,Jia, Jun,Bi, Xiaoxia...&Zhu, Yu.(2019).Apatinib monotherapy for chemotherapy-refractory metastatic colorectal cancer: A multicenter, single arm, prospective study..JOURNAL OF CLINICAL ONCOLOGY,37,(15)
MLA:
Wang, Fen,et al."Apatinib monotherapy for chemotherapy-refractory metastatic colorectal cancer: A multicenter, single arm, prospective study.".JOURNAL OF CLINICAL ONCOLOGY 37..15(2019)